Traditional passive transdermal techniques can leave more than 95% of the applied topical on the skin’s surface, even after many hours of exposure. DermaKinetics (DK) has been shown to significantly increase the quantity and depth of the applied topical (more than 50x) during one 30 min treatment.
What is it?
DermaKinetics is the only patented light based transdermal technology available that safely and effectively addresses a variety of cosmetic concerns and is far superior to other transdermal technologies currently available.
Unlike traditional LED light therapy DK's patented active transdermal delivery systems are not intended to use colors of light and photo energy to directly effect the tissue being treated. DK uses specific pulsed light energy to propel topically applied functional ingredients into various layers of the skin by utilizing specific pulsed visible incoherent light.
- Skin remains intact,
topicals remain chemically unchanged
- Safer than other transdermal technologies
- Hands-free and simple to administer
- Unrestrained by molecular weight
- Expandable to large body surface areas
- Predictable permeation depth
- Skin remains intact, topicals remain chemically unchanged
- Suitable for enhanced delivery of wide range of topicals
- Increases transdermal topical compound fluxes (flow)
- Effective on molecular weights from 168 Daltons to 2180 Kilodaltons
- Achieve significant intradermal concentrations compared to passive permeation
The DK platform also has been adapted for a variety of non-invasive drugs deliver applications under the name PhotoKinetics.
How does it work?
Upon excitation from patented DK wavelengths, molecules are induced into an excited energy state causing a temporary (reversible) conformational changes in the molecular shape.
Next, the molecules will revert to a resting state as the optical energy is dissipated during the “OFF” part of the cycle; which is repeated many times per second.
During the dissipation stage three mechanisms can occur: vibration, rotation and translocation; which creates movement of the molecule. Additionally, it is important to note that molecules will move away from the stimulation source (DK) and into the tissue.
Thus, when the patented DK light cycle is repeated, causing rapid shape change and physical movement on a molecular scale, the topical compound react and facilitate in the transdermal delivery into the tissue.
For more information on the technology, clinical studies, trials and papers please visit our Clinical page
For more information or to schedule an online training/demonstration please contact us at email@example.com or call 866.999.6954.